Promoter CpG island hypermethylation and down regulation of XRCC1 gene can augment in the gastric carcinogenesis events

Nissar, B and Kadla, S A and Wani, K A and Shah, I A and Ganai, B A (2021) Promoter CpG island hypermethylation and down regulation of XRCC1 gene can augment in the gastric carcinogenesis events. In: Molecular Biology Reports .

	PDF Mol_bio_rep_2021.pdf - Published Version Restricted to Registered users only Download (764kB) | Request a copy
	PDF 11033_2020_6064_MOESM1_ESM.pdf - Published Supplemental Material Restricted to Registered users only Download (83kB) | Request a copy

Abstract

Gastric cancer (GC) is a multistep process characterized by a gradual accumulation of genetic and epigenetic alterations in genes at various stages of progression. Epigenetic alterations like DNA methylation play an important role in cancer and may serve as a biomarker for cancer. The present study was aimed to investigate the promoter hypermethylation, expression profile, and Arg399Gln gene polymorphism of DNA repair gene XRCC1 (X-ray repair cross complimentary group I) in GC patients. A total of 60 histopathologically confirmed GC subjects were recruited in the study. Information on various dietary, lifestyle and environmental factors was obtained in face-to-face interviews using a structured questionnaire from each subject. Tissue samples were taken along with adjacent non-cancerous tissues for analysis. Promoter methylation status and expression of XRCC1 gene was evaluated using MS-PCR and western blotting respectively; while as Arg399Gln polymorphism was analyzed by PCR-RFLP. We found that the XRCC1 gene promoter of 38.3 cancerous tissues were methylated compared to 13.3 of adjacent normal tissues. The promoter hypermethylation status of the gene was found to be significantly associated with the loss of protein expression (P < 0.0001, OR = 14.63; 95 CI 4.01�53.43). However, we did not find any significant association of polymorphism of XRCC1 Arg399Gln with promoter methylation or protein expression. Further, comparison of methylation status and protein expression with clinical parameters like age, smoking status, etc. was also not significant (P > 0.05). The present study indicates that XRCC1 undergoes aberrant promoter hypermethylation with subsequent loss of protein expression in gastric cancer. © 2021, The Author(s), under exclusive licence to Springer Nature B.V. part of Springer Nature.

Item Type:	Journal Article
Publication:	Molecular Biology Reports
Publisher:	Springer Science and Business Media B.V.
Additional Information:	The copyright of this article belongs to Springer Science and Business Media B.V.
Department/Centre:	Division of Biological Sciences > Molecular Reproduction, Development & Genetics
Date Deposited:	17 Feb 2021 06:33
Last Modified:	17 Feb 2021 06:33
URI:	http://eprints.iisc.ac.in/id/eprint/67705

Actions (login required)

View Item